What Is the Role of ER Stress in the Heart? Introduction and Series Overview
Masafumi Kitakaze, Osamu Tsukamoto T hree decades ago, investigators studying the function of the endoplasmic reticulum (ER) focused on its role in transiently regulating Ca 2ϩ concentrations in cardiovascular cells. Muscle cells, including cardiomyocytes, contain a specialized smooth ER, the sarcoplasmic reticulum, and Ca 2ϩ release and reuptake by the sarcoplasmic reticulum trigger the contraction and relaxation of the myofibrils, respectively. Cardiovascular research has been focused on many aspects of muscle physiology, including myocardial contractility and relaxation, to better understand the regulation of systemic and cardiac hemodynamics. Furthermore, accumulating evidence indicates that perturbation in Ca 2ϩ homeostasis contributes to cardiovascular disease and is an effective therapeutic target for the treatment of heart disease. While intracellular Ca 2ϩ homeostasis was being investigated in great detail, a major discovery in ER biology was made in 1988, with the first description of the ER-stress response. 1 Although cardiovascular researchers did not initially enter this field, there has been a large shift in cardiovascular research toward this topic over the past several years.
To assess the significance of these findings, we must consider the functions of the ER. Cellular homeostasis and function require properly folded proteins. Protein folding is the process by which a linear polymer of amino acids acquires a unique 3D structure (the native conformation) capable of performing its cellular function(s). During the folding process, proteins often interact with molecular chaperones that bind to the hydrophobic regions of unfolded or incompletely folded proteins to facilitate proper folding but, perhaps more importantly, prevent the accumulation of misfolded proteins in toxic aggregates. Throughout their lifetime, cells are exposed to a range of environmental stressors, such as radiation, hypoxia, heat, osmotic shifts, and oxidation, and all of these can lead to the adoption of aberrant 3D structures in damaged proteins. 2 Cells carefully monitor for the presence of misfolded proteins in different compartments. The accumulation of misfolded proteins in the cytosol triggers a heat-shock response, which stimulates the transcription of genes encoding cytosolic chaperones to refold destabilized proteins. Similarly, the accumulation of misfolded proteins in the ER initiates a signaling cascade from the ER to the nucleus that induces a comprehensive gene expression program to increase the protein folding capacity of the cell according to need. 3 However, the mechanism and pathways that are essential for the ER to nucleus signaling were entirely unknown for quite some time.
Since the first description of the ER stress response, the contributions of many scientists have come to define the unfolded protein response (UPR), and it is now widely accepted that an imbalance between the delivery of unfolded proteins to the ER and the capacity of the cellular folding machinery leads to ER stress. 4 The ER has both smooth and rough regions. The rough ER forms stacks of flattened cisternae and is composed of a membrane-enclosed lumen. The smooth ER membrane is connected to these cisternae and forms a fine network of tubules. The smooth ER is the principal site of lipid synthesis and modification in specialized cells, including steroid hormonesecreting cells and hepatocytes. In contrast, the synthesis, modification, folding, and processing of nascent polypeptide chains of secreted, transmembrane, and luminal proteins occur in the rough ER. The presence of ribosomes on the cytosolic face of the ER gives rise to the rough ER, and ribosomes bind a single mRNA molecule and initiate protein synthesis. For nearly all proteins in the secretory pathway, a specific signal sequence is recognized by transmembrane proteins in the ER, and nascent polypeptides are then translocated across the ER membrane and become membrane imbedded or are released into the ER lumen. Within the ER, a number of different chaperones, including binding protein/glucose regulated protein (BiP/GRP)78, GRP94, calnexin, and calreticulin; and oxidoreductases, such as protein disulfide isomerase, ER protein (ERp)57, and ERp72, coordinately act to promote protein folding. 5 BiP/GRP78 is a homolog of heat shock protein 70, and GRP94 is a homolog of heat shock protein 90. Calnexin, calreticulin, and ERp57 specifically act on N-glycosylated proteins.
What is the UPR? The UPR was first studied in animal cells, where the expression of BiP/GRP78, GRP94, protein disulfide isomerase, ERp57, and/or ERp72 is induced by several different cellular stressors that lead to the accumulation of unfolded proteins in the ER. 1, 6 Additionally, the UPR is also active in unicellular organism such as the yeast Saccharomyces cerevisiae, 7, 8 and many of the proteins involved in the UPR are conserved across these diverse organisms, strongly indicating the importance of the ER protein folding machinery for cell survival. Despite this degree of conservation, higher eukaryotic organisms have evolved a more complex 3-pronged UPR signaling pathway involving PERK (pancreatic ER kinase), IRE1 (inositolrequiring transmembrane kinase/endonuclease 1), and ATF6 (activating transcription factor 6), whereas the pathway in yeast is linear involving only IRE1. 9 Our understanding of the cellular response to ER stress has dramatically increased over the past decade. 4 Recently, a novel cell-specific ER stress transducer 10 and a cell typespecific response to ER stress 11 have been discovered. The body of all higher animals is composed of heterogenous tissues and cells that are exposed to different cellular stressors in a tissue-specific manner, and this may contribute to the acquisition of specific morphology and function. These variations can extend to the ER. Cellular ER content and properties differ between cell types to accommodate specialized cellular functions. For example, highly differentiated cells that secrete large amounts of protein, such as exocrine acinar cells and plasma cells, have more extensive and better-developed rough ER than nonsecretory cells. Furthermore, the morphology and function of the rough ER can change in the same cell in response to a changing cellular environment. Stressed hypertrophic cardiomyocytes develop a more extensive rough ER than nonstressed cardiomyocytes. 12 The sensitivity of cells to ER stress also varies. When cardiomyocytes and cardiac fibroblasts are exposed to the same degree of ER stress, the cells respond differently with respect to transcriptional activity and apoptosis, and similar phenomena have been observed in the nervous system which is composed of different cell types such as neuronal and glial cells. 13 Thus, it is possible that cell-or organ-specific ER stress responses may take place, and future studies should focus on the specificity of the ER stress signaling and/or responses.
The role of UPR is among the most important areas of ongoing investigation into the pathogenesis of different disease states. Abnormalities in the UPR have been implicated in several diseases, including neurodegenerative diseases, 14, 15 bipolar disorder, 16 and both type 1 17, 18 and type 2 diabetes mellitus. 19, 20 Many lines of evidence indicate that the UPR and ER stress play an important role in the development of cardiovascular diseases. UPR activation is seen in both hypertrophic and failing hearts. Indeed, several studies suggest that the increased expression of CHOP (CCAAT/enhancer binding protein [C/EBP] homologous protein), a component of the ERinitiated apoptotic signaling pathway, may be involved in the transition from cardiac hypertrophy to heart failure. 12, 21 Additionally, an association between altered Ca 2ϩ handling, a common finding in patients with failing hearts, and UPR activation has also been reported. 22 The UPR is also activated in ischemic myocardium 23, 24 and the ER-initiated apoptotic signaling molecules, such as CHOP and caspase 12, may contribute to cardiomyocyte death after hypoxic insult. 25 The UPR is also activated in atherosclerotic lesions, and ER-initiated apoptotic signaling could contribute to plaque instability by inducing apoptosis in macrophages and smooth muscle cells. 26 -28 Atherosclerotic plaques are surrounded by potential sources of ER stress such as oxidized lipids, reactive oxygen species, metabolic stressors, and hypoxia. However, despite accumulating evidence documenting the crucial role of ER stress in the development of cardiovascular diseases, there is still much to learn about what could constitute an essential pathway in the pathogenesis of these disorders. In addition to its role in disease pathogenesis, the UPR may act as a protective response early during cell injury, but prolonged UPR activation is deleterious, leading to disturbed calcium homeostasis, increased protein accumulation, loss of ER function, and the death.
ER stress has recently become a potential target for new drug discovery in oncology, 29 and in cardiomyocytes, supplemental and/or pharmacological induction of GRP78 has been shown to attenuate ER stress-induced cell death. 30 In addition, it has been reported that chemical ER chaperones can reduce ER stress, 31 suggesting that small molecules can affect ER stress signaling in disease states. Given the possible development of novel UPR-targeted therapies for cardiovascular diseases, it is essential to know which components of the ER stress response to target and which particular disease stage will be most amenable to therapy.
This series contains reviews describing the present thinking about the role of ER stress in cardiovascular physiology and disease, as well as its potential therapeutic implications. A full understanding of the protein quality control network in the ER is becoming clearer, and the UPR and ER stress response are at the center of this network. This paradigm has evolved from the discovery in late 1980s that the accumulation of misfolded proteins in the ER initiates signaling to the nucleus to adjust the protein-folding capacity of the cell.
In this series, Marek Michalak, a recognized leader in the molecular biology of the ER, will provide an overview of the biology of ER stress with a focus on the heart. Cardiac hypertrophy and heart failure are common features of cardiovascular disease, and coronary artery diseases, including atherosclerosis, are the most prevalent cause of cardiac deaths worldwide. Accordingly, Rick Austin and Ira Tabas review the role of ER stress in cardiac tissues and coronary arteries, in both health and disease. Finally, we will discuss the molecular and pharmacological strategies that are needed to modulate ER stress for preventing cardiovascular diseases. Studies on the role of ER stress in cardiovascular disease are entering a new and exciting phase, and this review series promises to provide valuable insights into this emergent field of research.
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